J Korean Pediatr Cardiol Soc.  2007 Sep;11(3):215-221.

Comparison of Efficacy of Transcatheter Closure of Atrial Septal Defect with Amplatzer Septal Occluder between Children and Adult

Affiliations
  • 1Department of Pediatrics, Gil Medical Center, Gachon University of Medicine and Science, Incheon, Korea. pskcdy@hanmail.net
  • 2Department of Pediatrics, Halla General Hospital, Jeju, Korea.

Abstract

PURPOSE: This study sought to analyze the safety, efficacy, and follow-up results of percutaneous closure with Amplatzer septal occulder (ASO) for secundum atrial septal defect (ASD) in less than 10 years old by comparing to those of adult.
METHODS
We divided 49 enrolled subjects to two groups as childhood group (25 patients, 10< years) and adult group (24 patients, 20> years). We evaluated hemodynamic changes, including Qp/Qs, systolic right ventricular pressure, pulmonary artery pressure in pre- and post-treatment. The residual shunt rate and complications were investigated. Then, we compared the results between two groups.
RESULTS
The success rate of two groups was not statistically different (100% vs 95.8%). The hemodynamic changes, including Qp/Qs, systolic right ventricular pressure, pulmonary artery pressure were statistically significant between pre- and post-treatment (all P<0.05). However, hemodynamic change difference between children and adult group was not statistically significant (all P>0.2). The residual shunt rate and complications occurrence rate were not statistically significant between two groups.
CONCLUSION
The cure rate and complications by percutaneous closure of ASD with ASO were not different between in children and in adult. This procedure was an effective treatment modality for ASD in children like in adult.

Keyword

Atrial septal defect; Percutaneous

MeSH Terms

Adult*
Child*
Follow-Up Studies
Heart Septal Defects, Atrial*
Hemodynamics
Humans
Pulmonary Artery
Septal Occluder Device*
Ventricular Pressure
Full Text Links
  • JKPCS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr